Last reviewed · How we verify

NCT01941784

Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy

Completed NA Last updated 25 January 2019
What this trial tests

NA trial testing educational intervention in Stage IA Breast Cancer in 28 participants. Completed in 12 April 2017.

Timeline
25 November 2013
Primary endpoint
1 March 2017
12 April 2017

Quick facts

Lead sponsorWake Forest University Health Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment28
Start date25 November 2013
Primary completion1 March 2017
Estimated completion12 April 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Wake Forest University Health Sciences

Who can join

18 and older, female only, with Stage IA Breast Cancer or Stage IB Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot clinical trial studies a health education intervention in reducing weight gain in patients with newly diagnosed stage I-IV breast cancer undergoing chemotherapy. A health education program may reduce weight gain and improve quality of life in patients undergoing chemotherapy for breast cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of educational intervention

Trials testing the same drug.

Other recruiting trials for Stage IA Breast Cancer

Currently open trials in the same condition.

Other Wake Forest University Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01941784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing